Startups
Our unique formulation based on cutting-edge nanotechnology boosts the body's own capacity of self-healing and keeps bacterial infections in check. Our nanoparticle paste helps surgeons who want to ensure patient safety by reducing seromas and providing swift healing.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 2, 2020 | MassChallenge Switzerland reveals the 2020 cohort | |
| Jun 2, 2020 | MassChallenge Switzerland Announces 5th Cohort | June 2, 2020 (Renens, Switzerland) - MassChallenge Switzerland, part of MassChallenge’s global network of zero-equity startup accelerators, today announced its 2020 cohort, selected from more than 1,000 applications and representing some of... |
| Mar 18, 2020 | Nanoglue To Revolutionize Skin Transplantation | Nanoglue, a nanoparticle paste, promises to reduce infections, inflammation and supports wound healing to keep skin transplants alive. The company is a spin-off of the university research project, not been incorporated yet. The founders are... |
| Nov 29, 2019 | International recognition for Swiss startups | |
| Jul 30, 2019 | The AIT Brazil, Colombia and India startups revealed |
Reviews 0
FAQ about Nanoglue
What has the press written about Nanoglue?
Parsers VC has collected 6 articles mentioning Nanoglue, among them “MassChallenge Switzerland reveals the 2020 cohort” (Jun 2, 2020) and “MassChallenge Switzerland Announces 5th Cohort” (Jun 2, 2020).
Is Nanoglue still active?
Yes, Nanoglue is active; its latest activity on Parsers VC dates from Jun 2, 2020.